Christopher Hite
Director/Board Member presso ROYALTY PHARMA PLC
Patrimonio netto: 57 M $ in data 31/03/2024
Profilo
Christopher Hite's current jobs include serving as the Vice Chairman & Executive Vice President at RP Management LLC since 2020, and as the Vice Chairman & Executive Vice President at Royalty Pharma Plc since 2020.
He is also a Director at FasterCures and a Trustee at Lehigh University.
In his former positions, Mr. Hite worked as the Vice Chairman & Global Head-Healthcare at Citigroup, Inc. from 2008 to 2020.
He also served as an Independent Director at Acceleron Pharma, Inc. from 2020 to 2021, and as the Global Head-Healthcare Investment Banking at Lehman Brothers Holdings, Inc. from 2007 to 2008.
Additionally, he held a position as the Global Head-Healthcare at Community IT Innovators, Inc.Mr. Hite obtained a graduate degree and an MBA from the University of Pittsburgh.
He also holds an undergraduate degree from Lehigh University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 11/04/2023 | 1 176 160 ( 0.49% ) | 36 M $ | 31/03/2024 | |
RPI US Partners 2019 LP
0.29% | 23/03/2021 | 625 000 ( 0.29% ) | 19 M $ | 31/03/2024 |
| 11/04/2023 | 70 000 ( 0.02% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Christopher Hite
| Società | Posizione | Inizio |
|---|---|---|
| ROYALTY PHARMA PLC | Director/Board Member | 01/03/2020 |
RP Management LLC
 RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Director/Board Member | 01/03/2020 |
| FasterCures | Director/Board Member | - |
| Lehigh University | Director/Board Member | - |
Precedenti posizioni note di Christopher Hite
| Società | Posizione | Fine |
|---|---|---|
| ACCELERON PHARMA INC. | Director/Board Member | 19/11/2021 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/03/2020 |
Lehman Brothers Holdings, Inc.
 Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Lehman Brothers Holdings, Inc. engages in the provision of securities underwriting and investment services. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01/09/2008 |
Community IT Innovators, Inc.
 Community IT Innovators, Inc. Miscellaneous Commercial ServicesCommercial Services Community IT Innovators, Inc. provides business consulting services. The company was founded in 1993 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Formazione di Christopher Hite
| University of Pittsburgh | Graduate Degree |
| Lehigh University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CITIGROUP INC. | Finance |
| ROYALTY PHARMA PLC | Health Technology |
| Aziende private | 5 |
|---|---|
Lehman Brothers Holdings, Inc.
Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Lehman Brothers Holdings, Inc. engages in the provision of securities underwriting and investment services. The company is headquartered in New York, NY. | Finance |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
| FasterCures | |
RP Management LLC
RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Commercial Services |
Community IT Innovators, Inc.
Community IT Innovators, Inc. Miscellaneous Commercial ServicesCommercial Services Community IT Innovators, Inc. provides business consulting services. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
- Borsa valori
- Insiders
- Christopher Hite
